165 related articles for article (PubMed ID: 3121667)
1. Disk diffusion susceptibility testing and broth microdilution quality control guidelines for BMY-28100, a new orally administered cephalosporin.
Jones RN; Barry AL
J Clin Microbiol; 1987 Nov; 25(11):2211-3. PubMed ID: 3121667
[TBL] [Abstract][Full Text] [Related]
2. Ofloxacin susceptibility testing quality control parameters for microdilution and disk diffusion, and confirmation of disk diffusion interpretive criteria.
Fuchs PC; Jones RN; Barry AL; Gavan TL
J Clin Microbiol; 1989 Jan; 27(1):49-52. PubMed ID: 2492304
[TBL] [Abstract][Full Text] [Related]
3. Quality control parameters and interpretive criteria for in vitro susceptibility tests with the macrolide azithromycin. Collaborative Antimicrobial Susceptibility Testing Group.
Barry AL; Thornsberry C; Gavan TL
Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):544-9. PubMed ID: 2548865
[TBL] [Abstract][Full Text] [Related]
4. Single-strain regression analysis for determination of interpretive breakpoints for cefoperazone disk diffusion susceptibility testing.
Kronvall G
J Clin Microbiol; 1983 Jun; 17(6):975-80. PubMed ID: 6223938
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility testing quality control studies with fosfomycin tromethamine.
Fuchs PC; Barry AL; Brown SD
Eur J Clin Microbiol Infect Dis; 1997 Jul; 16(7):538-40. PubMed ID: 9272392
[TBL] [Abstract][Full Text] [Related]
6. Quality control limits for microdilution susceptibility tests with norfloxacin.
Barry AL; Gavan TL; Ayers LW; Fuchs PC; Gerlach EH; Thornsberry C
J Clin Microbiol; 1987 Jan; 25(1):165-6. PubMed ID: 3098779
[TBL] [Abstract][Full Text] [Related]
7. Assessment of BMS284756 MIC and 5-microg disk diffusion quality control studies tested against seven American type culture collection strains.
Biedenbach DJ; Jones RN;
Diagn Microbiol Infect Dis; 2001 Dec; 41(4):225-8. PubMed ID: 11777665
[TBL] [Abstract][Full Text] [Related]
8. Interpretive criteria and quality control limits for ceftibuten disk susceptibility tests. Collaborative Antimicrobial Susceptibility Testing Group.
Barry AL; Jones RN
J Clin Microbiol; 1990 Mar; 28(3):605-7. PubMed ID: 2182675
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility testing of carumonam: interpretive criteria for 30-microgram disk tests and quality control guidelines for disk diffusion and broth microdilution methods.
Jones RN; Barry AL
J Clin Microbiol; 1987 Nov; 25(11):2243-6. PubMed ID: 3693552
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of an orally administered cephalosporin, LY164846, against potentially pathogenic respiratory and dermal bacterial isolates.
Lauderdale BL; Yu PK; Washington JA
Antimicrob Agents Chemother; 1986 Apr; 29(4):560-4. PubMed ID: 3486628
[TBL] [Abstract][Full Text] [Related]
11. Disk agar diffusion susceptibility testing with 30-micrograms ceftazidime disks: confirmation of interpretive breakpoints and quality control guidelines.
Jones RN; Barry AL; Thornsberry C
J Clin Microbiol; 1983 Jul; 18(1):211-4. PubMed ID: 6350348
[TBL] [Abstract][Full Text] [Related]
12. Studies to optimize the in vitro testing of piperacillin combined with tazobactam (YTR 830).
Jones RN; Barry AL
Diagn Microbiol Infect Dis; 1989; 12(6):495-510. PubMed ID: 2560422
[TBL] [Abstract][Full Text] [Related]
13. Reevaluation of interpretive criteria for Haemophilus influenzae by using meropenem (10-microgram), imipenem (10-microgram), and ampicillin (2- and 10-microgram) disks.
Zerva L; Biedenbach DJ; Jones RN
J Clin Microbiol; 1996 Aug; 34(8):1970-4. PubMed ID: 8818892
[TBL] [Abstract][Full Text] [Related]
14. Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, beta-lactamase stability, and preliminary recommendations for disk diffusion testing.
Ayers LW; Jones RN; Barry AL; Thornsberry C; Fuchs PC; Gavan TL; Gerlach EH; Sommers HM
Antimicrob Agents Chemother; 1982 Nov; 22(5):859-77. PubMed ID: 6983862
[TBL] [Abstract][Full Text] [Related]
15. Cefoperazone disk diffusion susceptibility test: confirmation of the tentative interpretive criteria, Pseudomonas aeruginosa cross-resistance, and determination of quality control performance limits.
Jones RN; Gavan TL; Barry AL; Thornsberry C; Gibbs DL
J Clin Microbiol; 1982 May; 15(5):777-86. PubMed ID: 6212596
[TBL] [Abstract][Full Text] [Related]
16. Tentative disk diffusion susceptibility interpretive criteria for BMY-28142, a new cephalosporin.
Fuchs PC; Jones RN; Barry AL; Thornsberry C
J Clin Microbiol; 1986 Mar; 23(3):634-6. PubMed ID: 3754266
[TBL] [Abstract][Full Text] [Related]
17. Interpretive criteria and quality control for antimicrobial susceptibility tests of levofloxacin.
Barry A; Fuchs P; Tenover F; Allen S; Hardy D; Jorgensen J; McLaughlin J; Reller L
Eur J Clin Microbiol Infect Dis; 1994 Oct; 13(10):822-6. PubMed ID: 7889952
[TBL] [Abstract][Full Text] [Related]
18. Disk diffusion susceptibility testing for LY163892 (KT-3777), a new orally administered 1-carbacephem.
Jones RN; Barry AL
J Clin Microbiol; 1988 Apr; 26(4):770-3. PubMed ID: 3259247
[TBL] [Abstract][Full Text] [Related]
19. Interpretive standards and quality control guidelines for cefpiramide disk susceptibility tests.
Barry AL; Gavan TL; Thornsberry C; Jones RN
J Clin Microbiol; 1985 Oct; 22(4):688-90. PubMed ID: 4077974
[TBL] [Abstract][Full Text] [Related]
20. Determination of Disk Diffusion and MIC Quality Control Ranges for Nafithromycin (WCK 4873), a New Lactone-Ketolide.
Hackel MA; Karlowsky JA; Dressel D; Sahm DF
J Clin Microbiol; 2017 Oct; 55(10):3021-3027. PubMed ID: 28747372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
